The most distant part, overlapping the area where alternative splicing is presumed to occur, in the middle of the large exon of SSTR5 and the putative NAT promoter, was significantly less methylated in somatotropinomas than in NP. The gene discussed is BRD2; the disease is growth hormone-producing pituitary gland neoplasm.